Health care firm plans 500 jobs in Indianapolis
St. Louis-based Ascension Health announced Friday morning that it would open a professional service center in Indianapolis, creating up to 500 jobs by 2013.
Health Care & Insurance
Articles
Lender Oak Street acquired by New York firm
Carmel-based insurance lender Oak Street Funding LLC announced Thursday that it has been purchased by private equity funds managed by New York-based Angelo Gordon & Co.
Carmel couple donating $45M to University of Maryland
An Indiana couple is making a $45 million donation to the University of Maryland School of Medicine, which will use the money to establish a research center to study autoimmune and inflammatory diseases.
Zimmer quarterly profit jumps on lower costs
Warsaw-based Orthopedic implant maker Zimmer Holdings Inc. reported net income of $191.1 million, or 96 cents per share. Sales fell 1 percent to $965 million from $975.6 million.
Baldwin & Lyons reports lower profit, higher revenue
The insurer announced Thursday morning that it earned $9.2 million in the third quarter, down from $14.3 million a year ago. Quarterly revenue rose to $67.3 million, up from $65.5 million.
LEADING QUESTIONS: Home-health guru banks on empathy
Jan Roberts pairs numbers and nurturing—further fueled by a fight with breast cancer —to power the city's fifth largest woman-owned business.
After disagreement, Lewis leaves WellPoint with $3.2M
Dijuana Lewis will get nearly $3.2 million on her way out the door at WellPoint Inc. after what sources described as a dispute with CEO Angela Braly over a change in duties.
Employee ire forces IU to pull wellness survey
Indiana University will no longer ask employees to fill out an online health risk assessment after more than 550 people—many anonymous—attached names to an online petition that said the plan would cause “widespread anger and disillusionment.”
New estimate drops health plan’s cost to Indiana
A new estimate has lowered the expected cost of the federal health care overhaul to Indiana’s state government to perhaps $2.6 billion over the next decade.
Lilly diabetes setbacks may spur shopping for Amylin
Eli Lilly and Co., under pressure to gain new products after setbacks this month with two diabetes drugs, may try to acquire its partner Amylin Pharmaceuticals Inc.
WellPoint dismisses highly paid subsidiary CEO
Last year, Dijuana Lewis earned a $650,000 salary as one of the insurer’s highest paid executives and received a $200,000 bonus in part for helping to lead the sale of the NextRx subsidiary to Express Scripts Inc. for about $4.68 billion.
Analysts: Lilly setbacks might spur shopping spree
CEO John Lechleiter claims Eli Lilly and Co. isn’t interested in big acquisitions to bolster its flagging drug pipeline, but its recently devalued partner Amylin Pharmaceuticals might be the right fit, industry analysts say.
Analysts grill Lilly execs on strategy after setbacks
Wall Street analysts on Thursday demanded to know what new things Eli Lilly and Co. is planning since the company’s vaunted pipeline has failed to produce a drug that will boost revenue after a wave of patent expirations. The answer: Not much.
Home Health Depot acquires Arcadia subsidiary
The division purchased by Home Health Depot markets and sells home health related items via mail and online. Terms of the deal were not disclosed.
Lilly raises forecast after beating third-quarter profit estimates
The Indianapolis-based drugmaker reported a profit of $1.3 billion in the quarter ended Sept. 30, up 38 percent compared with last year. Excluding extraordinary items from a year ago, Lilly’s profit was up 2 percent.
Lilly suspends clinical trials after diabetes treatment fails
Eli Lilly and Co. and its development partner said an experimental diabetes treatment failed to help patients in a late-stage study, the second setback for a Lilly diabetes drug candidate in two days.
Indianapolis-area experts see bright spots amid ongoing real estate weakness
Health care shows signs of life, and multi-family buildings continue to hold their own, experts said during a recent IBJ Power Breakfast.
Principal Financial shift to result in local layoffs
Financial giant Principal Financial Group Inc. is exiting the health insurance business, a move that will cost 60 Indianapolis workers their jobs.
FDA demands more tests on new Lilly diabetes drug
Eli Lilly and Co. will have to wait at least 18 months and conduct more studies before it wins market approval of a once-weekly version of diabetes drug Byetta, a potential billion-dollar drug.
Q&A
Amy Zucker is president of Indianapolis-based Synergy Marketing Group. Her firm was recently hired by Indianapolis-based ImmuneWorks Inc. to use a new website and search engine optimization to help recruit patients for a Phase 1 trial of ImmuneWorks experimental medicine idiopathic pulmonary fibrosis. The Web strategy is a new wrinkle on patient recruitment—in addition to the traditional partnerships with disease specialists at academic medical centers—that Zucker hopes leads to lower costs and faster clinical trials. Phase 1 clinical trials cost nearly $16,000 per patient.